Ignite Creation Date:
2025-12-25 @ 1:16 AM
Ignite Modification Date:
2026-02-21 @ 5:57 AM
Study NCT ID:
NCT07007793
Status:
RECRUITING
Last Update Posted:
2025-10-10
First Post:
2025-05-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism
Sponsor:
AstraZeneca
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Primary Hyperaldosteronism | View |